Abstract
Considerable evidence points to a dominant role of inflammation in tumor pathology. The biological response of the immune system can be triggered by Toxoplasma gondii as a common brain-tropic parasite. The aim of this study was to investigate an association between Toxoplasma infection and brain tumors. This case-control study was performed on sera of brain tumor patients (n = 124) and age- and sex-matched control subjects (n = 124) in Southern Iran. Data related to tumor site and type were collected during sample collection. Anti-Toxoplasma IgG was assessed by enzyme-linked immunosorbent assay (ELISA). Seroprevalence anti-Toxoplasma IgG was significantly higher in brain tumor patients 30.6% (38/124) compared with 12.1% (15/124) of the healthy controls (OR 3.211; 95% CI 1.658 to 6.219; p = 0.001). The highest seroprevalence was detected in patients with ependymoma (100%), followed by glioblastoma (83%), pituitary adenoma (47.3%), astrocytoma (27.2%), schwannoma (23%), and meningioma (22.6%). The parasite infection was correlated to brain tumor’s location i.e., the patients with frontal lobe and sella region tumors had higher seropositivity compared with others (P < 0.05). The higher prevalence of Toxoplasma infection among patients with brain tumor compared with the control group indicates a probable association between the infection and brain tumors.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are included within the article.
References
Ahmadpour E et al (2014) Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries 8(12):1503–1510p
Arefkha N, Sarkari B, Afrashteh M, Rezaei Z, Dehghani M (2018) Toxoplasma gondii: the prevalence and risk factors in HIV-infected patients in Fars province, southern Iran. Iran Red Crescent Med J 20(6):e66521
Arefkhah N et al. (2019) Molecular genotyping and serological evaluation of Toxoplasma gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran. Comp. Immunol. Microbiol. Infect. Dis. 66101342
Bajelan S, Bahreini MS, Asgari Q, Mikaeili F (2020) Viability and infectivity of Toxoplasma gondii tachyzoites exposed to Butanedione monoxime. J Parasit Dis 44(4):822–828
Berenreiterová M, Flegr J, Kuběna AA, Němec P (2011) The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 6(12):e28925
Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel J (1995) A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 119(3):214–224
Cabral CM et al (2016) Neurons are the primary target cell for the brain-tropic intracellular parasite Toxoplasma gondii. PLoS Pathog 12(2):e1005447
Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ (2018) Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol 9:847
Cheeseman K, Certad G, Weitzman JB (2016) Parasites et cancer: existe-t-il un lien? Med Sci (Paris) 32(10):867–873
Cong W et al (2015) Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett 359(2):307–313
Correia da Costa JM et al (2014) Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers. Front. Genet 5:444
Dai W, Pan H, Kwok O, Dubey J (1994) Human indoleamine 2, 3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J Interferon Res 14(6):313–317
Daryani A et al (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop 137:185–194
Facer CA, Playfair J (1989) Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv. Cancer Res 53:33–72
Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Fisch D, Clough B, Frickel E-M (2019) Human immunity to Toxoplasma gondii. PLoS Pathog 15(12):e1008097
Jung B-K et al (2016) High Toxoplasma gondii seropositivity among brain tumor patients in Korea. Korean J Parasitol 54(2):201
Kalantari N et al (2015) Preliminary study on association between toxoplasmosis and breast cancer in Iran. Asian Pac J Trop Biomed 5(1):44–47
Khabaz MN, Elkhateeb L, Al-Alami J (2011) Reactivation of latent Toxoplasma gondii in immunocompromised cancer patients. Comp Clin Path 20(2):183–186
Kim SK, Boothroyd JC (2005) Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J Immunol Res 174(12):8038–8048
Laliberte J, Carruthers VB (2008) Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 65(12):1900–1915
Lehrer S (2010) Association between malaria incidence and all cancer mortality in fifty US States and the District of Columbia. Anticancer Res 30(4):1371–1373
Mendez OA, Koshy AA (2017) Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. PLoS Pathog 13(7):e1006351
Molan AL, Rasheed EH (2016) Study the possible link between toxoplasmosis and different kinds of cancer in Iraq. Am J Life Sci 4:3
Mostafa NES et al (2018) The relationship between toxoplasmosis and different types of human tumors. J Infect Dev Ctries 12(02):137–141
Nourollahpour Shiadeh M et al (2016) The correlation between Toxoplasma gondii infection and prenatal depression in pregnant women. Eur J Clin Microbiol 35(11):1829–1835
Oh JK, Weiderpass E (2014) Infection and cancer: global distribution and burden of diseases. Ann Glob Health 80(5):384–392
Pang JC, Kwok WK, Chen Z, Ng H-K (2009) Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 117(6):599–611
Powell H, Gibbs C, Lorenzo A, Lampert P, Gajdusek D (1978) Toxoplasmosis of the central nervous system in the adult. Electron microscopic observations. Acta Neuropathol 41(3):211–216
Remington JS, Cavanaugh EN (1965) Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med 273(24):1308–1310
Rostami A et al (2020) Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis.Clin. Microbiol Infect 26(6):673–683
Ryan P et al (1993) Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol 22(3):412–419
Saadat F et al (2020) Seroepidemiology and associated risk factors of Toxoplasma gondii in hemodialysis patients. Acta Parasitol 65(4):906–912
Sarkari B, Shafiei R, Zare M, Sohrabpour S, Kasraian L (2014) Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. J Infect Dev Ctries 8(04):543–547
Schuman LM, Choi N, Gullen W (1967) Relationship of central nervous system neoplasms to Toxoplasma gondii infection. Am J Public Health 57(5):848–856
Thirugnanam S, Rout N, Gnanasekar M (2013) Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAsInfect. Agents Cancer 8(1):1–6
Thomas F et al (2012) Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol Lett 8(1):101–103
Vittecoq M et al (2012) Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect Genet Evol 12(2):496–498
Yuan Z et al (2007) Toxoplasma gondii antibodies in cancer patients. Cancer Lett 254(1):71–74
Zeiner GM, Norman KL, Thomson JM, Hammond SM, Boothroyd JC (2010) Toxoplasma gondii infection specifically increases the levels of key host microRNAs. PLoS ONE 5(1):e8742
Acknowledgements
This study was financially supported by the office of vice chancellor for research of Shiraz University of Medical Sciences (Grant no. 95-01-01-12998).
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Contributions
QA and NA designed the study; FR and MS B collected the samples; NA, FR carried out the serological method; FS and NA analyzed and interpreted the data. NA drafted the manuscript; FS performed final revision and editing; all the authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Disclosure
This study was the subject of the MD dissertation for Mr. Farshad Rajabi.
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Asgari, Q., Rajabi, F., Sajadian, F. et al. Toxoplasma gondii infection in patients with brain tumors in Southern Iran: a case-control study. J Parasit Dis 47, 291–296 (2023). https://doi.org/10.1007/s12639-022-01541-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-022-01541-y